CastleKnight Management LP Reduces Holdings in Ardent Health, Inc. $ARDT

Posted by George Bondi on Jun 18th, 2026

CastleKnight Management LP trimmed its position in shares of Ardent Health, Inc. (NYSE:ARDT – Free Report) by 32.8% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,167,947 shares of the company’s stock after selling 570,969 shares during the quarter. CastleKnight Management LP owned approximately 0.82% of Ardent Health worth $10,313,000 as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in ARDT. Goldentree Asset Management LP increased its position in shares of Ardent Health by 99.7% during the fourth quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company’s stock worth $20,302,000 after purchasing an additional 1,150,000 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Ardent Health by 1,684.9% during the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock worth $10,558,000 after purchasing an additional 724,841 shares in the last quarter. Ameriprise Financial Inc. increased its position in shares of Ardent Health by 75.6% during the second quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock worth $22,332,000 after purchasing an additional 703,739 shares in the last quarter. Bridgeway Capital Management LLC increased its position in shares of Ardent Health by 108.2% during the fourth quarter. Bridgeway Capital Management LLC now owns 946,571 shares of the company’s stock worth $8,358,000 after purchasing an additional 491,961 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC purchased a new stake in shares of Ardent Health during the third quarter worth approximately $6,377,000.

Analyst Ratings Changes

ARDT has been the subject of several analyst reports. Weiss Ratings restated a “sell (d+)” rating on shares of Ardent Health in a report on Friday, June 12th. Zacks Research upgraded Ardent Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 25th. Leerink Partners dropped their target price on Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a report on Friday, March 6th. UBS Group upped their target price on Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a report on Thursday, May 7th. Finally, Wall Street Zen upgraded Ardent Health from a “hold” rating to a “buy” rating in a report on Saturday, May 16th. Seven investment analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Ardent Health presently has a consensus rating of “Hold” and a consensus target price of $14.21.

Check Out Our Latest Stock Analysis on ARDT

Ardent Health Stock Performance

NYSE ARDT opened at $9.11 on Thursday. The stock has a market cap of $1.31 billion, a PE ratio of 9.58, a P/E/G ratio of 2.10 and a beta of 0.84. The company has a current ratio of 2.12, a quick ratio of 2.00 and a debt-to-equity ratio of 0.62. Ardent Health, Inc. has a twelve month low of $7.71 and a twelve month high of $15.48. The stock has a fifty day simple moving average of $9.51 and a 200-day simple moving average of $9.13.

Ardent Health (NYSE:ARDT – Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.28 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.10. The business had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Ardent Health had a return on equity of 13.85% and a net margin of 2.09%.Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. Equities analysts anticipate that Ardent Health, Inc. will post 1.11 earnings per share for the current year.

Insider Buying and Selling at Ardent Health

In other Ardent Health news, CFO Alfred Lumsdaine purchased 10,000 shares of the stock in a transaction dated Friday, June 5th. The stock was acquired at an average cost of $8.81 per share, for a total transaction of $88,100.00. Following the acquisition, the chief financial officer owned 329,183 shares in the company, valued at $2,900,102.23. This trade represents a 3.13% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.90% of the company’s stock.

Ardent Health Company Profile

(Free Report)

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.